Pancreatic Cancer Research

ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Till Sebastian Clauditz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4257-856X; OpenAlex author ID A5079884607. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper

Papers 3

  1. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. Co-author DOI 10.1177/03946320221106504↗
  2. Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer Aggressiveness. Co-author DOI 10.1080/07357907.2021.1943747↗
  3. DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. Last author DOI 10.7717/peerj.11905↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Till Krech · 3 shared papers, 2021–2022 · strength 0.31
  2. Jakob Robert Izbicki · 3 shared papers, 2021–2022 · strength 0.31
  3. Kristina Jansen · 2 shared papers, 2021 · strength 0.20
  4. Sören Alexander Weidemann · 1 shared paper, 2021 · strength 0.11
  5. Sebastian Dwertmann Rico · 1 shared paper, 2022 · strength 0.11
  6. Andreas M. Luebke · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.